A Study of The Effects of Co-Administering Ciprofloxacin and BioThrax on the Pharmacokinetics of Ciprofloxacin in Healthy Adults

Trial Profile

A Study of The Effects of Co-Administering Ciprofloxacin and BioThrax on the Pharmacokinetics of Ciprofloxacin in Healthy Adults

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2014

At a glance

  • Drugs Anthrax vaccine (Primary) ; Ciprofloxacin (Primary)
  • Indications Anthrax
  • Focus Pharmacokinetics; Registrational
  • Sponsors Emergent BioSolutions
  • Most Recent Events

    • 16 Apr 2014 Emergent BioSolutions has submitted the final clinical study report to the Biomedical Advanced Research and Development Authority (BARDA) and the US FDA.
    • 16 Apr 2014 Primary endpoint 'Peak-drug-concentration' has been met.
    • 16 Apr 2014 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top